Device Trial Radar · NCT07523204
Photobiomodulation Therapy for Scar Quality After Facial Wound Closure
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
41
Actual
Start
Oct 17, 2024
Primary completion
Oct 20, 2026
Study completion Oct 20, 2026
Sponsor
- Lead sponsor
- Hani M. Al-KufiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 13, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 13 years, up to 47 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study tested whether photobiomodulation therapy (PBMT), a treatment that uses laser light, could improve scar quality after a facial injury. Participants whose wounds were closed with stitches were randomly assigned to receive either PBMT or a simulated treatment without therapeutic laser light. Both procedures began after the stitches were removed. Participants and a clinician rated scar quality 3 and 12 months after the last session.
Conditions
- Traumatic Facial Wounds
Interventions
Photobiomodulation Therapy (PBMT)Device
PBMT began after suture removal and was delivered using a 940 nm diode laser (Epic X, BIOLASE) set to 2 W in continuous-wave mode. The nominal beam diameter was 3 cm, corresponding to a spot area of approximately 7.1 cm² and an irradiance of approximately 0.28 W/cm². Each site was exposed for 20 seconds, corresponding to 40 J per site and a calculated radiant exposure of approximately 5.6 J/cm². The transparent handpiece attachment rested against the skin during application. Ten sessions were scheduled at three sessions per week.
Sham Photobiomodulation TherapyDevice
The sham procedure began after suture removal and used the same device, handpiece, and application sites as active PBMT, with 20 seconds per site. The footswitch was not pressed, so no therapeutic laser light was emitted. Ten sessions were scheduled at three sessions per week.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Scar Quality Assessed by POSASTime frame: 3 months and 12 months after completion of treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Oral and Maxillofacial Surgery, College of Dentistry, The Islamic University, Najaf, Iraq
Kufa, Najaf, Iraq
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.